Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.900
+0.010 (0.35%)
At close: Apr 1, 2025, 4:00 PM
2.960
+0.060 (2.07%)
After-hours: Apr 1, 2025, 7:17 PM EDT

Daré Bioscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-4.05-30.16-30.95-38.7-27.4
Upgrade
Depreciation & Amortization
0.040.040.020.030.04
Upgrade
Loss (Gain) From Sale of Assets
0.6----
Upgrade
Stock-Based Compensation
2.22.532.161.60.74
Upgrade
Other Operating Activities
0.790.08-0.02-0.42-0.16
Upgrade
Change in Accounts Receivable
0.720.75-0.56-0.690.1
Upgrade
Change in Accounts Payable
-1.931.36-0.081.08-0.06
Upgrade
Change in Unearned Revenue
2.82-4.577.768.980.54
Upgrade
Change in Other Net Operating Assets
4.2-8.893.57-0.650.96
Upgrade
Operating Cash Flow
5.39-38.86-18.09-28.76-25.23
Upgrade
Capital Expenditures
-0.57-0.63-0.06-0.01-0.02
Upgrade
Investing Cash Flow
-0.57-0.63-0.06-0.01-0.02
Upgrade
Short-Term Debt Issued
----0.37
Upgrade
Long-Term Debt Issued
0.560.6---
Upgrade
Total Debt Issued
0.560.6--0.37
Upgrade
Long-Term Debt Repaid
-0.58-0.33---
Upgrade
Net Debt Issued (Repaid)
-0.020.27--0.37
Upgrade
Issuance of Common Stock
0.4510.651.3475.8524.76
Upgrade
Other Financing Activities
-04.72---
Upgrade
Financing Cash Flow
0.4315.641.3475.8525.13
Upgrade
Foreign Exchange Rate Adjustments
-0.07-0.01-0.2-0.060.01
Upgrade
Miscellaneous Cash Flow Adjustments
0----
Upgrade
Net Cash Flow
5.19-23.86-1747-0.11
Upgrade
Free Cash Flow
4.82-39.49-18.15-28.78-25.25
Upgrade
Free Cash Flow Margin
49276.38%-1406.26%-181.52%--
Upgrade
Free Cash Flow Per Share
0.57-5.43-2.58-5.65-10.07
Upgrade
Levered Free Cash Flow
-9.82-27.18-6.8-15.28-15.27
Upgrade
Unlevered Free Cash Flow
-9.82-27.18-6.8-15.28-15.27
Upgrade
Change in Net Working Capital
-5.379.91-10.7-7.53-1.09
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q